Search research articles
Contact Us
Filters
Showing results (121-130 of 173) with videos related to
Page
of 18
Sort By:
Breast Cancer Research and Treatment
|
February 14, 2015
Impact of body mass index on neoadjuvant treatment outcome: a pooled analysis of eight prospective neoadjuvant breast cancer trials
Caterina Fontanella, Bianca Lederer, Stephan Gade, et al.
Geburtshilfe Und Frauenheilkunde
|
August 4, 2017
Initial Treatment of Patients with Primary Breast Cancer: Evidence, Controversies, Consensus: Spectrum of Opinion of German Specialists at the 15th International St. Gallen Breast Cancer Conference (Vienna 2017)
Michael Untch, Jens Huober, Christian Jackisch, et al.
Breast Cancer Research and Treatment
|
March 19, 2017
Efficacy and safety of nab-paclitaxel 125 mg/m<sup>2</sup> and nab-paclitaxel 150 mg/m<sup>2</sup> compared to paclitaxel in early high-risk breast cancer. Results from the neoadjuvant randomized GeparSepto study (GBG 69)
Jenny Furlanetto, Christian Jackisch, Michael Untch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 24, 2010
Neoadjuvant treatment with trastuzumab in HER2-positive breast cancer: results from the GeparQuattro study
Michael Untch, Mahdi Rezai, Sibylle Loibl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 24, 2010
Capecitabine in addition to anthracycline- and taxane-based neoadjuvant treatment in patients with primary breast cancer: phase III GeparQuattro study
Gunter von Minckwitz, Mahdi Rezai, Sibylle Loibl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 27, 2011
Cytoplasmic poly(adenosine diphosphate-ribose) polymerase expression is predictive and prognostic in patients with breast cancer treated with neoadjuvant chemotherapy
Gunter von Minckwitz, Berit Maria Müller, Sibylle Loibl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 11, 2009
Neoadjuvant chemotherapy shows similar response in patients with inflammatory or locally advanced breast cancer when compared with operable breast cancer: a secondary analysis of the GeparTrio trial data
Serban Dan Costa, Sibylle Loibl, Manfred Kaufmann, et al.
Anti-Cancer Drugs
|
March 16, 2019
A randomized phase II study to determine the efficacy and tolerability of two doses of eribulin plus lapatinib in trastuzumab-pretreated patients with HER-2-positive metastatic breast cancer (E-VITA)
Joachim Bischoff, Jana Barinoff, Christoph Mundhenke, et al.
The New England Journal of Medicine
|
December 12, 2024
Axillary Surgery in Breast Cancer - Primary Results of the INSEMA Trial
Toralf Reimer, Angrit Stachs, Kristina Veselinovic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 3, 2019
Prospective, Multicenter, Randomized Phase III Trial Evaluating the Impact of Lymphoscintigraphy as Part of Sentinel Node Biopsy in Early Breast Cancer: SenSzi (GBG80) Trial
Sherko Kuemmel, Johannes Holtschmidt, Bernd Gerber, et al.
Page
of 18
Search research articles
Search
Showing results (121-130 of 173) with videos related to
Sort By:
Page
of 18
Breast Cancer Research and Treatment
|
February 14, 2015
Impact of body mass index on neoadjuvant treatment outcome: a pooled analysis of eight prospective neoadjuvant breast cancer trials
Caterina Fontanella, Bianca Lederer, Stephan Gade, et al.
Geburtshilfe Und Frauenheilkunde
|
August 4, 2017
Initial Treatment of Patients with Primary Breast Cancer: Evidence, Controversies, Consensus: Spectrum of Opinion of German Specialists at the 15th International St. Gallen Breast Cancer Conference (Vienna 2017)
Michael Untch, Jens Huober, Christian Jackisch, et al.
Breast Cancer Research and Treatment
|
March 19, 2017
Efficacy and safety of nab-paclitaxel 125 mg/m<sup>2</sup> and nab-paclitaxel 150 mg/m<sup>2</sup> compared to paclitaxel in early high-risk breast cancer. Results from the neoadjuvant randomized GeparSepto study (GBG 69)
Jenny Furlanetto, Christian Jackisch, Michael Untch, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 24, 2010
Neoadjuvant treatment with trastuzumab in HER2-positive breast cancer: results from the GeparQuattro study
Michael Untch, Mahdi Rezai, Sibylle Loibl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 24, 2010
Capecitabine in addition to anthracycline- and taxane-based neoadjuvant treatment in patients with primary breast cancer: phase III GeparQuattro study
Gunter von Minckwitz, Mahdi Rezai, Sibylle Loibl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 27, 2011
Cytoplasmic poly(adenosine diphosphate-ribose) polymerase expression is predictive and prognostic in patients with breast cancer treated with neoadjuvant chemotherapy
Gunter von Minckwitz, Berit Maria Müller, Sibylle Loibl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 11, 2009
Neoadjuvant chemotherapy shows similar response in patients with inflammatory or locally advanced breast cancer when compared with operable breast cancer: a secondary analysis of the GeparTrio trial data
Serban Dan Costa, Sibylle Loibl, Manfred Kaufmann, et al.
Anti-Cancer Drugs
|
March 16, 2019
A randomized phase II study to determine the efficacy and tolerability of two doses of eribulin plus lapatinib in trastuzumab-pretreated patients with HER-2-positive metastatic breast cancer (E-VITA)
Joachim Bischoff, Jana Barinoff, Christoph Mundhenke, et al.
The New England Journal of Medicine
|
December 12, 2024
Axillary Surgery in Breast Cancer - Primary Results of the INSEMA Trial
Toralf Reimer, Angrit Stachs, Kristina Veselinovic, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 3, 2019
Prospective, Multicenter, Randomized Phase III Trial Evaluating the Impact of Lymphoscintigraphy as Part of Sentinel Node Biopsy in Early Breast Cancer: SenSzi (GBG80) Trial
Sherko Kuemmel, Johannes Holtschmidt, Bernd Gerber, et al.
Page
of 18